CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-13 | MOEBIUS HANS Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,881 | 7,882 | ||
| 2022-06-30 | PERCEPTIVE ADVISORS LLC Director | Purchase | +1,101,362 | $2.99 | $3.3M | 4,797,278 |
| 2022-06-29 | PERCEPTIVE ADVISORS LLC Director | Purchase | +270,000 | $2.99 | $807K | 3,695,916 |
| 2022-06-28 | MOEBIUS HANS Chief Medical Officer | Purchase | +10,000 | $2.88 | $29K | 52,955 |
| 2022-06-23 | Worthington Mark General Counsel | Sale | −2,614 | $2.69 | $7K | 19,097 |
| 2022-06-23 | MILESON GLENNA Chief Financial Officer | Sale | −2,614 | $2.69 | $7K | 109,167 |
| 2022-06-23 | Litton Mark James Chief Executive Officer | Sale | −7,960 | $2.69 | $21K | 128,555 |
| 2022-06-23 | Lenington Rachel Chief Operating Officer | Sale | −4,193 | $2.69 | $11K | 5,807 |
| 2022-06-23 | CHURCH KEVIN Executive VP, Research | Sale | −2,614 | $2.69 | $7K | 57,695 |
| 2022-06-22 | Worthington Mark General Counsel | Grant or award | +10,000 | 21,711 | ||
| 2022-06-22 | MOEBIUS HANS Chief Medical Officer | Grant or award | +10,000 | 42,955 | ||
| 2022-06-22 | MILESON GLENNA Chief Financial Officer | Grant or award | +10,000 | 111,781 | ||
| 2022-06-22 | Litton Mark James Chief Executive Officer | Grant or award | +20,000 | 136,515 | ||
| 2022-06-22 | Lenington Rachel Chief Operating Officer | Grant or award | +10,000 | 10,000 | ||
| 2022-06-22 | CHURCH KEVIN Executive VP, Research | Grant or award | +10,000 | 60,309 | ||
| 2022-06-08 | CHURCH KEVIN Executive VP, Research | Exercise or conversion | +2,500 | $1.35 | $3K | 50,309 |
| 2022-06-08 | CHURCH KEVIN Executive VP, Research | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 10,110 | ||
| 2022-05-20 | PICKERING GRANT Director | Grant or award · Stock Option (Right to Buy) | +3,467 | 3,467 | ||
| 2022-05-20 | Romano Kelly A Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2022-05-20 | Kosacz Barbara Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 |
Page 13 of 18 · 349 trades